Table 4.
Medication class and drug name | Extent of drug–drug interaction with rivaroxaban | ||
---|---|---|---|
None/not clinically relevant (routine co-administration possible) | Moderate clinical relevance (co-administer with caution) | High clinical relevance (avoid co-administration) | |
HIV protease inhibitors | |||
Ritonavir | X | ||
Azole-antimycotics | |||
Ketoconazole | X | ||
Fluconazole | X | ||
Antibiotics | |||
Clarithromycin | X | ||
Erythromycin | X | ||
Rifampicin | X | ||
Anticoagulants | |||
Enoxaparin | X | ||
Warfarin | Xa | ||
NSAIDs and platelet inhibitors | |||
Naproxen | X | ||
Clopidogrel | X | ||
Aspirin | X | ||
Cardiac medications | |||
Digoxin | X | ||
Atorvastatin | X | ||
Dronedarone | Xb | ||
Stomach acid regulators | |||
Ranitidine | X | ||
Aluminium-magnesium hydroxide (antacid) | X | ||
Sedatives | |||
Midazolam | X | ||
Antidepressants | |||
St John’s wort | X | ||
Anticonvulsants | |||
Phenytoin | X | ||
Carbamazepine | X | ||
Phenobarbital | X |
aExcept when switching; bbased on a lack of clinical information.
HIV, human immunodeficiency virus; NSAID, non-steroidal anti-inflammatory drug.